Complement factor H interferes with Mycobacterium bovis BCG entry into macrophages and modulates the pro-inflammatory cytokine response

Immunobiology

Volumn 221, Issue 9, 2016, Pages 944-952

  Abdul Aziz, Munirah ^a,b   Tsolaki, Anthony G ^b   Kouser, Lubna ^b   Carroll, Maria V ^a   Al Ahdal, Mohammed N ^d   Sim, Robert B ^a,c   Kishore, Uday ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Complement; Cytokine; Factor H; Macrophage; Mycobacterium; Phagocytosis; Tuberculosis

Indexed keywords

COMPLEMENT COMPONENT C4 BINDING PROTEIN; COMPLEMENT FACTOR H; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; C4BPA PROTEIN, HUMAN; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H, HUMAN;

ARTICLE; BACTERIAL SURVIVAL; CONTROLLED STUDY; CYTOKINE RESPONSE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUBERCULOSIS; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; COMPLEMENT C4B-BINDING PROTEIN; COMPLEMENT FACTOR H; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MYCOBACTERIUM BOVIS; PHAGOCYTOSIS;

EID: 84973884422     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2016.05.011     Document Type: Article

References (44)

1. Ajona D., Castano Z., Garayoa M., Zudaire E., Pajares M.J., Martinez A., Cuttitta F., Montuenga L.M., Pio R. Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement. Cancer Res. 2004, 64:6310-6318.
2. Ajona D., Hsu Y.F., Corrales L., Montuenga L.M., Pio R. Down-regulation of human complement factor H sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth. J. Immunol. 2007, 178:5991-5998.
3. Ansari M., McKeigue P.M., Skerka C., Hayward C., Rudan I., Vitart V., Polasek O., Armbrecht A.M., Yates J.R., Vatavuk Z., Bencic G., Kolcic I., Oostra B.A., Van Duijn C.M., Campbell S., Stanton C.M., Huffman J., Shu X., Khan J.C., Shahid H., Harding S.P., Bishop P.N., Deary I.J., Moore A.T., Dhillon B., Rudan P., Zipfel P.F., Sim R.B., Hastie N.D., Campbell H., Wright A.F. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum. Mol. Genet. 2013, 22:4857-4869.
4. Blom A.M., Webb J., Villoutreix B.O., Dahlback B. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function. J. Biol. Chem. 1999, 274:19237-19245.
5. Carroll M.V., Sim R.B. Complement in health and disease. Adv. Drug Deliv. Rev. 2011, 63:965-975.
6. Carroll M.V., Lack N., Sim E., Krarup A., Sim R.B. Multiple routes of complement activation by Mycobacterium bovis BCG. Mol. Immunol. 2009, 46:3367-3378.
7. China B., Sory M.P., N'Guyen B.T., De Bruyere M., Cornelis G.R. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 1993, 61:3129-3136.
8. Dannenberg A.M. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 1991, 12:228-233.
9. Demangel C., Bertolino P., Britton W.J. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur. J. Immunol. 2002, 32:994-1002.
10. Diaz A., Ferreira A., Sim R.B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J. Immunol. 1997, 158:3779-3786.
11. Diaz A., Willis A.C., Sim R.B. Expression of the proteinase specialized in bone resorption, cathepsin K, in granulomatous inflammation. Mol. Med. 2000, 6:648-659.
12. Diaz A., Casaravilla C., Allen J.E., Sim R.B., Ferreira A.M. Understanding the laminated layer of larval Echinococcus II: immunology. Trends Parasitol. 2011, 27:264-273.
13. Ehlers S., Schaible U.E. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 2012, 3:411.
14. Ehlers S., Benini J., Held H.D., Roeck C., Alber G., Uhlig S. Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology. J. Exp. Med. 2001, 194:1847-1859.
15. Feng C.G., Kaviratne M., Rothfuchs A.G., Cheever A., Hieny S., Young H.A., Wynn T.A., Sher A. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 2006, 177:7086-7093.
16. Ferguson J.S., Weis J.J., Martin J.L., Schlesinger L.S. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect. Immun. 2004, 72:2564-2573.
17. Gong J.H., Zhang M., Modlin R.L., Linsley P.S., Iyer D., Lin Y., Barnes P.F. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect. Immun. 1996, 64:913-918.
18. Gupta A., Kaul A., Tsolaki A.G., Kishore U., Bhakta S. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 2012, 217:363-374.
19. Hallstrom T., Zipfel P.F., Blom A.M., Lauer N., Forsgren A., Riesbeck K. Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 2008, 181:537-545.
20. Hellwage J., Meri T., Heikkila T., Alitalo A., Panelius J., Lahdenne P., Seppala I.J., Meri S. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J. Biol. Chem. 2001, 276:8427-8435.
21. Hirsch C.S., Ellner J.J., Russell D.G., Rich E.A. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 1994, 152:743-753.
22. Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:1657-1661.
23. Hu C., Mayadas-Norton T., Tanaka K., Chan J., Salgame P. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J. Immunol. 2000, 165:2596-2602.
24. Kertesz Z., Yu B.B., Steinkasserer A., Haupt H., Benham A., Sim R.B. Characterization of binding of human beta 2-glycoprotein I to cardiolipin. Biochem. J. 1995, 310(Pt. 1):315-321.
25. Kishore U., Sim R.B. Factor H as a regulator of the classical pathway activation. Immunobiology 2012, 217:162-168.
26. Kuhn S., Zipfel P.F. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 1996, 26:2383-2387.
27. Leal I.S., Smedegard B., Andersen P., Appelberg R. Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine. Infect. Immun. 1999, 67:5747-5754.
28. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Nunez G., Schlueter D., Flavell R.A., Sutterwala F.S., Sher A. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010, 184:3326-3330.
29. O'Leary S., O'Sullivan M.P., Keane J. IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages. Am. J. Respir. Cell Mol. Biol. 2011, 45:172-180.
30. Pietikainen J., Meri T., Blom A.M., Meri S. Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol. Immunol. 2010, 47:1299-1305.
31. Rooijakkers S.H., van Strijp J.A. Bacterial complement evasion. Mol. Immunol. 2007, 44:23-32.
32. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 1990, 144:2771-2780.
33. Schneider M.C., Prosser B.E., Caesar J.J., Kugelberg E., Li S., Zhang Q., Quoraishi S., Lovett J.E., Deane J.E., Sim R.B., Roversi P., Johnson S., Tang C.M., Lea S.M. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 2009, 458:890-893.
34. Schwaeble W., Zwirner J., Schulz T.F., Linke R.P., Dierich M.P., Weiss E.H. Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. Eur. J. Immunol. 1987, 17:1485-1489.
35. Shaw T.C., Thomas L.H., Friedland J.S. Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. Cytokine 2000, 12:483-486.
36. Sim E., Wood A.B., Hsiung L.M., Sim R.B. Pattern of degradation of human complement fragment, C3b. FEBS Lett. 1981, 132:55-60.
37. Sim E., Palmer M.S., Puklavec M., Sim R.B. Monoclonal antibodies against the complement control protein factor H (beta 1 H). Biosci. Rep. 1983, 3:1119-1131.
38. Sim R.B., Day A.J., Moffatt B.E., Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 1993, 223:13-35.
39. Smith D., Hansch H., Bancroft G., Ehlers S. T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-alpha and interferon-gamma. Immunology 1997, 92:413-421.
40. Thern A., Stenberg L., Dahlback B., Lindahl G. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J. Immunol. 1995, 154:375-386.
41. Theus S.A., Cave M.D., Eisenach K.D. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect. Immun. 2004, 72:1169-1173.
42. Tian T., Woodworth J., Skold M., Behar S.M. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J. Immunol. 2005, 175:3268-3272.
43. Tsolaki A.G. Innate immune recognition in tuberculosis infection. Adv. Exp. Med. Biol. 2009, 653:185-197.
44. Zumla A., Raviglione M., Hafner R., von Reyn C.F. Tuberculosis. N. Engl. J. Med. 2013, 368:745-755.